Literature DB >> 28702157

Food bioactive componts, a possible adjuvant for H.pylori eradication.

Soheil Ebrahimpour1, Haleh Esmaeili2, Reza Ghadimi2.   

Abstract

Entities:  

Keywords:  Helicobacter pylori; adjuvant therapy; dietary bioactive components

Year:  2017        PMID: 28702157      PMCID: PMC5494052          DOI: 10.22088/cjim.8.2.131

Source DB:  PubMed          Journal:  Caspian J Intern Med        ISSN: 2008-6164


× No keyword cloud information.
Dear Editor, Helicobacter pylori (H. pylori) is a Gram-negative bacillus. Since its discovery in the early eighties by warren and marshall, for the first time in the history of medicine H. pylori was isolated from human gastric biopsy specimens (1). Many studies have presented that H. pylori can be isolated from the oral cavity and salivary secretions. Colonization of the gastric pits in the stomach by this brachium is a serious risk factor for peptic ulcers and stomach cancer (2). Several antibiotic regimens have been assessed for H. pylori therapy. Despite that, few regimens have shown high eradication rates. Therapeutic regimens of H. pylori infection are usually based on at least two types of antibiotics (imidazoles, macrolides and amoxicillin) combined with a double dose of the proton-pump inhibitor (omeprazole or pantoprazole). The problem of eradication therapy is the potentially undesirable increasing resistance of H. pylori to the commonly used antibiotics. Moreover, eradication therapy is associated with some side effects. Long-term therapy with the antibiotic can result in pervasive alterations in gut flora and lead to susceptibility infections. So, the development of the adjuvant therapy for the eradication of H. pylori which also prevent adverse side effects would be a valuable item. Accordingly, different potential adjuvant therapies for H. pylori have been considered. The major research on alternative therapies contains foods like plant origin, probiotics, and polysaccharides. Some compounds from medicinal plants with anti-H.pylori activity consist of polyphenolic, sulforaphane, flavonoids, carvacrol, tannins, quercetin and β-hydrastine (3, 4). Green tea contains polyphenols, which hamper the growth of bacteria. Some studies have shown that drinking green tea can decrease H. pylori colonization during standard treatments (5). Broccoli sprouts (high in sulphorafane), cruciferous vegetables include kale, cabbage, cauliflower, brussels sprouts, red-headed cabbage, and radishes (high in isothiocyanates) can diminish the H. pylori growth (6). Apples contain flavonoids that defend the lining materials of the stomach against H.pylori infection (7). Honey exhibits potent in vitro bacteriostatic activity against H. pylori and inhibits urease activity. Antibacterial activity of honey is attributable to its hydrogen peroxide content (5). Probiotic bacteria can modulate H. pylori activity by either immunological (reduction of IL-1 and IL-6) or non-immunological mechanisms (competition with potential microorganisms) (3). Therefore, the use of antibiotics as first-line therapies may be appropriate for the eradication of H.pylori, but the results confirm the medicinal properties of some foods and compounds as a new adjuvant therapy for H.pylori eradication. Moreover, further studies should be required to support their use.
  7 in total

1.  Helicobacter pylori infection appears the prime risk factor for stomach cancer.

Authors:  Shinkan Tokudome; Reza Ghadimi; Sadao Suzuki; Akihiro Hosono; Tsutomu Tanaka; Kazuyuki Arakawa; Yang Zhao; Nami Hattori; Hiroyuki Agawa; Mitsuhiro Marumoto; Ryosuke Ando; Malcolm A Moore
Journal:  Int J Cancer       Date:  2006-12-15       Impact factor: 7.396

2.  Honey and green/black tea consumption may reduce the risk of Helicobacter pylori infection.

Authors:  Lyudmila Boyanova; Juliana Ilieva; Galina Gergova; Borislav Vladimirov; Rossen Nikolov; Ivan Mitov
Journal:  Diagn Microbiol Infect Dis       Date:  2015-03-06       Impact factor: 2.803

3.  In vitro inhibitory effect of apple peel extract on the growth of Helicobacter pylori and respiratory burst induced on human neutrophils.

Authors:  Edgar Pastene; Hernán Speisky; Miriam Troncoso; Julio Alarcón; Guillermo Figueroa
Journal:  J Agric Food Chem       Date:  2009-09-09       Impact factor: 5.279

4.  Dietary sulforaphane-rich broccoli sprouts reduce colonization and attenuate gastritis in Helicobacter pylori-infected mice and humans.

Authors:  Akinori Yanaka; Jed W Fahey; Atsushi Fukumoto; Mari Nakayama; Souta Inoue; Songhua Zhang; Masafumi Tauchi; Hideo Suzuki; Ichinosuke Hyodo; Masayuki Yamamoto
Journal:  Cancer Prev Res (Phila)       Date:  2009-04

Review 5.  Treatment of Helicobacter pylori infection: Current and future insights.

Authors:  Maliheh Safavi; Reyhaneh Sabourian; Alireza Foroumadi
Journal:  World J Clin Cases       Date:  2016-01-16       Impact factor: 1.337

6.  Helicobacter pylori infection and metabolic parameters: is there an association in elderly population?

Authors:  Narges Sotuneh; Seyed Reza Hosseini; Javad Shokri-Shirvani; Ali Bijani; Reza Ghadimi
Journal:  Int J Prev Med       Date:  2014-12

7.  Helicobacter pylori antibiotic resistance: Can herbal medicine be an alternative for the treatment?

Authors:  Mohammad Zamani; Vahid Zamani
Journal:  J Res Med Sci       Date:  2016-11-02       Impact factor: 1.852

  7 in total
  2 in total

Review 1.  Helicobacter pylori infection in children: an overview of diagnostic methods.

Authors:  Parisa Sabbagh; Mostafa Javanian; Veerendra Koppolu; VeneelaKrishna Rekha Vasigala; Soheil Ebrahimpour
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-02-07       Impact factor: 3.267

2.  Double strain probiotic effect on Helicobacter pylori infection treatment: A double-blinded randomized controlled trial.

Authors:  Mehdi Haghdoost; Sepehr Taghizadeh; Majid Montazer; Parinaz Poorshahverdi; Ali Ramouz; Sanam Fakour
Journal:  Caspian J Intern Med       Date:  2017
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.